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ABSTRACT
The generation of genetic epidemiological data in Africa to drive public education on 
the biological basis of substance use disorders (SUDs), which has been popularly mis-
construed as a moral failure, has become imperative, in order to encourage access to 
formal care by patients. This study aimed to determine the morbid risks of SUDs among 
the first-degree relatives (FDRs) of probands with alcohol use disorder (AUD) and can-
nabis use disorder (CUD), in comparison with the families of healthy control group. The 
study elicited information on the morbid risk of SUDs among FDRs of probands with 
AUD and CUD and relatives of a healthy control group through direct interview or by 
proxy interview of relatives using the Family Interview for Genetic Studies (FIGS). The 
best-estimate method was used for the diagnosis in the relatives of the probands and 
a comparison group. Logistic regression was used to estimate the odds ratios (OR) and 
95% confidence intervals (CI) for the differences in proportion of the affected versus 
unaffected FDRs, while the Weinberger method was used to estimate morbid risks. The 
morbid risks among FDRs of probands with AUD and CUD were 17.5(95% CI, 17.1-17.9) 
and 11.6(11.2-12.0), respectively, in comparison with 7.8(95% CI, 7.6-8.0) and 5.7(95% 
CI, 5.5-5.9), respectively, for the FDRs of the controls. The increased familial risk of SUDs 
among FDRs of probands with alcohol and cannabis use disorders in an African popula-
tion is similar to that in the Western population. Therefore, preventive strategies involv-
ing the family may be useful.
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Substance Use Disorders (SUDs) also 
known as Drug Use Disorders (DUDs), 
refers to a condition in which the use of 
one or more substances leads to a clini-
cally significant distress or impairment 
(Van Den Bree & Pickworth, 2005). The 
term encompasses acute intoxication, 
harmful use, dependence syndrome, 
withdrawal states with or without de-
lirium, psychotic disorders, and amnesic 
syndrome (World Health Organization, 
1994). The health consequences of il-
licit drug use continue to be a matter of 
global concern, as a majority of problem 
drug users continues to have no access 
to treatment (United Nation Office on 
Drug and Crime, 2015). The use of psy-
choactive substances poses a significant 
threat to the health, social, and eco-
nomic fabric of families, communities, 
and nations (United Nation Office on 
Drug and Crime, 2015). According to the 
World Health Organization Global Bur-
den of Diseases report, substance use 
disorders contributed 12.4% of cases of 
death worldwide in the year 2000. It also 
accounted for 8.9% of total years lost to 
disability (World Health Organization, 
1994). Understanding its etiology espe-
cially in low resource settings will guide 
the development of evidence-based pre-
ventive interventions.
There is increasing evidence that sub-
stance use disorders are familial and that 
genetic factors explain a substantial de-
gree of their familial aggregation (Weiss-
man et al., 1986; Meller et al., 1988; 
Bierut et al., 1998; Verhulst et al., 2015; 
Merikangas et al., 2009; Merikangas et al., 
1998). Controlled family studies as well 
as clinical and epidemiological studies 
have demonstrated the extent to which 
substance use disorders are familial, 
with some specificity of familial aggre-
gation found for some drugs (Weissman 
et al., 1986; Meller et al., 1988). In one 
controlled family study of SUDs, an eight-
fold increased risk of drug use disorders 
among relatives of affected probands was 
found compared to those of psychiatric 
and unaffected controls (Merikangas et 
al., 1998).
The identified pathways of familial ag-
gregation include shared genetic envi-
ronments in which, for some substances 
like alcohol use disorders have been esti-
mated to have 50% heritability (Verhulst 
et al., 2015). Twin studies have shown 
that genetic factors explain a portion of 
the variance in the familial aggregation 
of substance use disorders (Verhulst et 
al., 2015; Heath, 1995), while, adoption 
studies have confirmed the heritability of 
substance use disorders, they also high-
light the importance of the interaction 
between genetic and environmental fac-
tors in the development of substance use 
disorders (Verhulst et al., 2015; Heath, 
1995). Other pathways include, paren-
tal and sibling substance abuse (Ouzir & 
Errami, 2016), and assortative mating, 
where a high concordance was observed 
for SUDs between spouses (Homish et al., 
2007).
There is dearth of data on the heri-
tability of SUDs in Africa. To the best of 
the authors’ knowledge this was the first 
report from our continent regarding the 
familial and morbid risks of SUDs using 
our methodology. This study addressed 
this question; what is the morbid risk of 
alcohol use disorder and cannabis use dis-
order among the first-degree relatives of 
probands with alcohol and cannabis use 
disorders compared to first-degree rela-
tives of a healthy control group?
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METHOD
Study design and population
This was a controlled family study using 
a cross-sectional design. Patients admit-
ted into the drug treatment unit of the 
Federal Neuropsychiatric Hospital, Enugu, 
South-Eastern Nigeria were the probands 
for this family study. The hospital serves 
the entire South-Eastern states and neigh-
boring geopolitical zones. The hospital 
offers both acute and long term care for 
psychiatric in-patients with a comprehen-
sive drug treatment program in collabora-
tion with United Nations Office on Drug 
and Crime (UNODC). The healthy control 
group consisted of physically and men-
tally healthy staff of Enugu North council 
secretariat.
Probands
Probands with lifetime diagnoses of 
alcohol and cannabis use disorders that 
were stable enough to understand and 
follow the interview process, and gave 
permission for their relatives to be ap-
proached were included in the study. 
Those with significant organic mental 
impairment and other major psychiatric 
disorders (schizophrenia, schizoaffec-
tive disorders, bipolar disorders, and 
major depressive disorders) were ex-
cluded based upon review by clinicians 
with expertise in substance abuse. The 
sample was composed of a total of 112 
probands with diagnosis of SUDs (34 
probands of alcohol use disorder and 43 
probands of cannabis use disorder), and 
35 control from the Local Council secre-
tariat staff. The comparison group was 
conveniently selected to match similar 
characteristics of age and sex of the 
probands. Participants in the compari-
son group were included if they had no 
history of substance use disorders and 
gave permission for the relatives to be 
approached.
Relatives
There were a total of 940 first-degree 
relatives, 315 relatives of probands with 
alcohol use disorder (68 parents, 155 
siblings and 92 children), 347 relatives 
of probands with cannabis use disor-
ders (86 parents, 237 siblings and 24 
children), and 278 relatives of the con-
trol (70 parents, 172 siblings and 36 chil-
dren). Fifty nine, 64 and 13 relatives of 
the probands with alcohol use disorder, 
cannabis use disorder and the healthy 
control group, respectively were inter-
viewed directly (in person or via phone 




Substance use disorders were estab-
lished using Mini International Neuro-
psychiatric Interview (MINI), current and 
lifetime versions (Sheehan et al., 1998). 
The MINI differs from other diagnostic 
instruments in that is semi-structured 
and administered by experienced clinical 
interviewers in a much shorter time, as 
opposed to highly structured Composite 
International Diagnostic Interview (CIDI) 
or Diagnostic Interview Schedule (DIS) 
used by lay interviewers. Two interview-
ers with experience in clinical psychiatry 
and substance abuse conducted the diag-
nostic interviews to establish the diagno-
sis of substance use disorder using DSM-5 
criteria. Kappa derived from joint ratings 
of individual interviews were good (0.64-
0.86) for substance use disorders in the 
first six training sessions.
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The family history information
Family history information was obtained 
via direct interview of available relatives, or 
through telephone interviews or via proxy 
interviews for unavailable relatives using 
the Family Interview for Genetic Studies 
(National Institute of Mental Health Genet-
ics Initiative, 1992). The Family Interview 
for Genetic Studies (FIGS) was developed 
by principal investigators in the National 
Institute of Mental Health (NIMH) Schizo-
phrenia and Bipolar Disorder Genetics 
initiatives and NIMH extramural program 
staff in 1992, as a guide for systematically 
collecting information about relatives in 
family genetic studies of these disorders. It 
comprises of the general screening ques-
tions, the face sheet, and the symptom 
checklists. The most general information 
is gathered using the general screening 
questions about all known relatives in the 
pedigree, regardless of how distantly relat-
ed. The face sheet is for each of the infor-
mant’s first degree relatives, and also for 
any affected relatives about whom the in-
formant can provide the information. The 
various symptom checklists (depression, 
mania, alcohol, and other drug abuses, 
psychosis, schizoid/paranoid/schizotypal 
personality disorders) are used to ferret 
out the diagnostic details that help make 
possible best estimate diagnosis. Direct 
interviews and family history are far more 
concordant for observable disorders such 
as drug abuse and behavior disorders than 
for less readily observable disorders such 
as mood and anxiety disorders.
Diagnostic procedures
Diagnoses of substance use disorders 
among first-degree relatives and spouses 
were based upon all available information, 
including the diagnostic interview, family 
history reports and medical records, using 
the best estimate method of diagnosis. 
Best estimate diagnosis was made by two 
clinicians with extensive experience in the 
evaluation and treatment of substance 
abuse, and who were blind with respect to 
the diagnostic status of the probands when 
making the best-estimates of the relatives. 
In case of doubt a third opinion was sought. 
Interview status was included as a covari-
ate in the analysis because of the well-es-
tablished underestimation of diagnoses in 
the non-interviewed relatives.
Ethical Consideration
Ethical approval was obtained from the 
Research and Ethics Committee of the 
Federal Neuropsychiatric Hospital Enugu, 
Enugu state, Nigeria. International Ethi-
cal norms and standards were strictly ad-
hered to at all times.
Data Analysis
The Weinberg method for age correc-
tion was used to calculate the lifetimes at 
risk (morbid risk) for each group of first-
degree relatives (Weinberg, 2010). The 
Weinberg estimator for lifetime morbid 
risk is given by: W-MR = A/A + 0.5U2 + U3. 
Where, A = the number of affected rela-
tives of a certain class (e.g. first-degree, 
etc.).U1 = the number of unaffected sub-
jects who were younger than the minimal 
risk period of age. U2 = the number of un-
affected subjects who were within the pe-
riod of risk. U3 = the number of unaffected 
subjects who were older than the maximal 
period age. The corrected denominator, 
often referred to by the German term Be-
zugsziffer, or BZ, is meant to approximate 
the number of lifetime at risk subjects. 
Limits for age of risk of 15-55 years for 
substance use disorders were used in this 
study due to a recent report of age distri-
bution of substance use disorder in Nigeria 
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(Adamson et al., 2015). Logistic regression 
analyses were used to estimate odd ratios 
(OR) and 95% confidence interval (CI) for 
the differences in the proportion of affect-
ed versus unaffected first-degree relatives, 
controlling for probands sex, interview sta-
tus (direct versus proxy interview).
RESULTS
A total of 112 participants (34 alcohol 
use disorder, 43 cannabis use disorder and 
35 healthy control group) and their 940 
relatives (315 of AUD, 347 of CUD and 278 
of the control group) participated in the 
study. The three groups were similar in age 
(p = 0.13) and gender (p = 0.57). Majority 
(71.4%) of the control group were married 
(p < 0.001) as shown in Table 1. The socio-
demographic characteristic of the rela-
tives is shown in Table 2. The table shows 
that the relatives were similar in the num-
ber of FDRs (p = 0.15), parents (p = 1.00), 
siblings (p = 0.20) and age (p > 0.05). They 
however differ in the number of children 
(p < 0.001). The proportion of the affected 
first-degree relatives of the probands 
with alcohol use disorder and the control 
group were 8.9% vs. 4.7%, parents (35.3% 
vs. 7.1%) and siblings (15.5% vs. 5.2%), re-
spectively. For relatives of the probands 
with cannabis use disorder, the propor-
tion of the affected FDRs in comparison 
with the healthy control group were 5.8% 
vs. 2.0%, parents (8.1% vs. 5.7%), and 
siblings (9.7% vs. 3.5%), respectively. The 
morbid risk (95% confidence interval) of 
alcohol use disorder among the FDRs of 
the probands with AUD versus the FDRs 
of a healthy control group were 17.5(95% 
CI, 17.1-17.9) vs. 7.8(95%CI, 7.6-8.0) for all 
FDRs, 39.0(95% CI, 37.4-40.6) vs. 7.1(95% 
CI, 6.2-8.0) for parents and 27.3(95% CI, 
26.3-28.3) vs. 4.4(95% CI, 4.0-4.8) for the 
siblings. Similarly, the morbid risk (95% 
confidence interval) of cannabis use disor-
der among the FDRs of the probands with 
CUD versus the FDRs of a healthy control 
group were 11.6(95% CI, 11.2-12.0) vs. 
5.7(95% CI, 5.5-5.9) for all FDRs, 8.4(95% 
CI, 7.8-9.0) vs. 6.3(95% CI, 5.5-7.1) for 
parents and 24.5(95% CI, 23.5-25.5) and 
20.7(95% CI, 18.0-23.4) for the siblings.






(n = 35) 
Statistics
Mean Age in years (SD) 34.5(9.7) 30.5(6.8) 33.0(9.0) F = 2.1, p = 0.13
Mean Age at First Use (SD) 19.9(6.6) 20.9(7.1) t = –0.6, p = 0.54






































c2 = 49.1, p < 0.001
NB: SD = Standard Deviation
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Table 2. Socio-demographic characteristics of the first-degree relatives of the study 
participants
Variables FDRs Alcohol 
Probands (n = 315)
FDRs Cannabis 




Number of FDRs 315 347 278 F = 1.9, p = 0.15
Number of Parents 68 86 70 F = 0.0, p = 1.00
Number of Siblings 155 237 172 F = 1.6, p = 0.20
Number of Children 92 24 36 F = 12.3, p < 0.001
Mean Age of Parents 59.5 ± 7.9 58.0 ± 7.3 59.5 ± 7.9 F = 0.5, p = 0.63
Mean Age of Siblings 28.6 ± 10.2 29.4 ± 10.5 30.1 ± 10.3 F = 0.5, p = 0.58
Mean Age of Children 7.9 ± 5.6 8.7 ± 5.7 9.4 ± 6.9 F = 0.6, p = 0.59
Mean Age of Spouse 25.1 ± 4.6 24.5 ± 4.3 26.7 ± 3.9 F = 0.4, p = 0.66
FDRs aged <15years 67 40 35 F = 5.4, p = 0.006
FDRs aged 15-55 years 160 228 161 F = 1.2, p = 0.31
FDRs aged >55years 88 79 82 F = 4.7, p = 0.11
NB: FDRs = First-Degree-Relatives
Table 3. Morbid Risk of substance use disorders among first-degree relatives of 
probands with alcohol and cannabis use disorders
Variables 
Alcohol Use Disorders Cannabis Use Disorders
Probands Control Probands Control 
All FDRs
 No of Affected FDRs
 % Affected FDRs
 BZ (SUD) of FDRs




























 No of Affected Parents
 % Affected Parents
 BZ (SUD) of parents




























 No of Affected Siblings
 % Affected Siblings
 BZ (SUD) of Siblings



























NB: SUD = Substance Use Disorders, FDRs = First-Degree Relatives, 95%C.I = 95% Confidence Interval, BZ = Bezugsziffer
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Table 4. Logistic Regression analyses for the differences in the affected versus 
unaffected first-degree relatives of probands with alcohol use disorder
AUDs in Relatives Probands (AUDs) Control p-value O.R (95%C.I)











































NB: AUDs = Alcohol Use Disorder; FDRs = First-Degree Relatives; O.R = Odd Ratios; 95%C.I = 95% Confidence Intervals
Table 5. Logistic Regression analyses for the differences in the affected versus 
unaffected first-degree relatives of probands with cannabis use disorder
CUDs in Relatives Probands (CUDs) Control p-value O.R (95%C.I)











































NB: CUDs = Cannabis Use Disorder; FDRs = First-Degree Relatives; O.R = Odd Ratios; 95%C.I = 95% Confidence Intervals
DISCUSSION
The general aim of the current study 
was to determine the morbid risk of al-
cohol and cannabis use disorders among 
FDRs of probands with alcohol and can-
nabis use disorders, in comparison with a 
sample of healthy control population. This 
study to the best of authors’ knowledge is 
the first African study to examine familial 
transmission of SUDs using this method-
ology. The highlights of the findings of this 
genetic epidemiology study are: (1) the 
proportion of affected FDRs of probands 
with alcohol use disorder, in comparison 
with FDRs of the control group were 8.9% 
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and 4.7%, respectively; (2) the proportion 
of affected FDRs of probands with canna-
bis use disorder, in comparison with FDRs 
of the control group were 5.9% and 2.0%, 
respectively; (3) the proportion of affect-
ed spouse and young children in probands 
with substance use disorders were not 
different from those of the control group; 
(4) the morbid risk of alcohol use disorder 
among FDRs of probands with alcohol use 
disorder and FDRs of a healthy control 
group were 17.5(95% C1, 17.1-17.9) and 
7.8(95% CI, 7.6-8.0), respectively; and (5) 
the morbid risk of cannabis use disorder 
among FDRs of probands with cannabis 
use disorder and FDRs of a healthy con-
trol group were 11.6(95% C1, 11.2-12.0) 
and 5.7(95% CI, 5.5-5.9), respectively.
The results of the present study show 
that alcohol and cannabis use disorders 
aggregate in the families of probands with 
alcohol and cannabis use disorders. The 
morbid risk of AUD and CUD among FDRs 
of probands with AUD and CUD were 17.5 
and 11.6 versus 7.8 and 5.7 of the con-
trols, respectively. The elevation of risk of 
substance use disorders among FDRs of 
the probands as shown in the study dem-
onstrates that having a family history of 
substance use disorder is one of the most 
potent risk factors for the development of 
SUDs. The increased risk of SUDs among 
FDRs of probands with SUDs is consistent 
with previous family reports (Verhulst et 
al., 2015; Merikangas et al., 2009; Meri-
kangas et al., 1998). Merikangas et al., 
(1998) found an 8-fold increased risk of 
drug use disorders among FDRs of rela-
tives with wide range of SUDs.
The results also show a significant de-
gree of familial clustering of SUDs among 
parents and siblings of probands with 
SUDs. This is consistent with reports that 
show high level of familial transmission of 
SUDs within sibling pairs relative to con-
trol (Merikangas et al., 2009; Merikangas 
et al., 1998). Familial aggregation was 
not demonstrated among children of the 
probands with SUDs in this study. This is 
contrary to a previous report which found 
increased risk of SUDs in adult children of 
probands with SUDs (Merikangas et al., 
1998). One plausible explanation of our 
result is the age of the children involved 
in our study. The mean age of the children 
in this study were 7.9 years, 8.7 years and 
9.4 years for AUD probands, CUD pro-
bands and controls, respectively. These 
age groups are below the age at maxi-
mal risk for SUDs (Adamson et al. 2015). 
Studies that reported familial aggrega-
tion among children were on adult chil-
dren of the probands (Merikangas et al., 
2009; Merikangas et al., 1998). Similarly, 
the present study did not find any concor-
dance between probands with SUDs and 
their spouses. Some family studies have 
reported high concordance rate between 
probands and their spouses (Merikangas 
et al., 1998; Homish et al., 2007), a phe-
nomenon they explained using assorta-
tive mating (Homish et al., 2007). Our 
finding could be explained by the small 
number of married probands (18 for AUD 
probands and 12 for CUD probands). In 
addition, cultural factors in some African 
societies that restrict certain behaviors 
among females (e.g., smoking and drink-
ing) may have influenced our findings.
Familial aggregation has been described 
as the occurrence of a trait in more mem-
bers of a family than can be readily ac-
counted for by chance alone (Mifflin, 
2004)]. Though this is not a sufficient 
proof of genetic transmission, it is a pre-
requisite for further genetic studies. The 
pathways to familial clustering of SUDs 
may be related to either common genetic 
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or environmental factors (Verhulst et al., 
2015; Bailey & Hubbard, 1990). Genetic 
factors could increase the vulnerability to 
the development of SUDs through individ-
ual differences with respect to the drug ef-
fects (e.g., pharmacokinetic or pharmaco-
dynamic differences) (Bailey & Hubbard, 
1990). Families may transmit the risk of 
SUDs through direct mechanisms (e.g., 
genes, increasing environmental expo-
sure to drugs or facilitating drug availabil-
ity) or through indirect mechanisms (e.g., 
impaired parenting behavior, exposure to 
marital discord, social deprivation etc.) 
(Robins, 1980; Brown, 1989).
One limitation of this study was the use 
of family history method predominantly 
to elicit family history information; al-
though it saved cost and time, the lack of 
sensitivity for many psychiatric disorders 
is a major drawback. Direct interview, 
while having its problems such as selec-
tion bias could have made more rigor-
ous diagnosis possible. However, in this 
study the magnitude of this problem was 
reduced by controlling for the interview 
status in the analysis, and the finding that 
family history methods is more concor-
dant to direct interviews for observable 
disorders like substance use disorders. In 
addition, the relatively small sample size 
in our study is another limitation. The 
number of female participants was too 
small to make comparison whether the 
risk is different between the genders.
CONCLUSION
The findings of this study suggest that 
alcohol and cannabis use disorders aggre-
gate in the families of the probands with 
SUDs. This study has enriched the field of 
genetic epidemiology of SUDs in Africa by 
providing valuable data to aid clinicians’ 
public education and preventive services 
of genetic counseling in Africa.
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